These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9631956

  • 1. Chronic haloperidol produces a time- and dose-related slowing of lick rhythm in rats: implications for rodent models of tardive dyskinesia and neuroleptic-induced parkinsonism.
    Fowler SC, Wang G.
    Psychopharmacology (Berl); 1998 May; 137(1):50-60. PubMed ID: 9631956
    [Abstract] [Full Text] [Related]

  • 2. Haloperidol-induced decrements in force and duration of rats' tongue movements during licking are attenuated by concomitant anticholinergic treatment.
    Fowler SC, Das S.
    Pharmacol Biochem Behav; 1994 Dec; 49(4):813-7. PubMed ID: 7886092
    [Abstract] [Full Text] [Related]

  • 3. Effects of haloperidol and clozapine on tongue dynamics during licking in CD-1, BALB/c and C57BL/6 mice.
    Wang G, Fowler SC.
    Psychopharmacology (Berl); 1999 Nov; 147(1):38-45. PubMed ID: 10591867
    [Abstract] [Full Text] [Related]

  • 4. Acute and subchronic effects of clozapine on licking in rats: tolerance to disruptive effects on number of licks, but no tolerance to rhythm slowing.
    Das S, Fowler SC.
    Psychopharmacology (Berl); 1995 Aug; 120(3):249-55. PubMed ID: 8524971
    [Abstract] [Full Text] [Related]

  • 5. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS, Kulkarni SK.
    Eur J Pharmacol; 2001 Sep 28; 428(1):81-6. PubMed ID: 11779040
    [Abstract] [Full Text] [Related]

  • 6. Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats.
    Shireen E, Naeem S, Inam QU, Haleem DJ.
    Pak J Pharm Sci; 2013 Mar 28; 26(2):271-6. PubMed ID: 23455196
    [Abstract] [Full Text] [Related]

  • 7. Haloperidol-induced tardive dyskinesia in monkeys.
    Gunne LM, Bárány S.
    Psychopharmacology (Berl); 1976 Nov 24; 50(3):237-40. PubMed ID: 826968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An update of Fowler and Das: anticholinergic reversal of haloperidol-induced, within-session decrements in rats' lapping behavior.
    Das S, Fowler SC.
    Pharmacol Biochem Behav; 1996 Apr 24; 53(4):853-5. PubMed ID: 8801588
    [Abstract] [Full Text] [Related]

  • 10. Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia.
    Hashimoto T, Ross DE, Gao XM, Medoff DR, Tamminga CA.
    Psychopharmacology (Berl); 1998 May 24; 137(2):107-12. PubMed ID: 9629996
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M, Chopra K, Kulkarni SK.
    Pharmacol Biochem Behav; 2008 Feb 24; 88(4):511-22. PubMed ID: 18022680
    [Abstract] [Full Text] [Related]

  • 12. Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.
    Hyde TM, Egan MF, Wing LL, Wyatt RJ, Weinberger DR, Kleinman JE.
    Psychopharmacology (Berl); 1995 Mar 24; 118(2):142-9. PubMed ID: 7617800
    [Abstract] [Full Text] [Related]

  • 13. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
    Psychopharmacology (Berl); 1986 Mar 24; 90(4):423-9. PubMed ID: 2880362
    [Abstract] [Full Text] [Related]

  • 14. A new rodent model for neuroleptic-induced pseudo-parkinsonism: low doses of haloperidol increase forelimb tremor in the rat.
    Fowler SC, Liao RM, Skjoldager P.
    Behav Neurosci; 1990 Jun 24; 104(3):449-56. PubMed ID: 2354039
    [Abstract] [Full Text] [Related]

  • 15. Emergence of oral and locomotor activity in chronic haloperidol-treated rats following cortical N-methyl-D-aspartate stimulation.
    Grimm JW, Kruzich PJ, See RE.
    Pharmacol Biochem Behav; 1998 May 24; 60(1):167-73. PubMed ID: 9610939
    [Abstract] [Full Text] [Related]

  • 16. Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia.
    Singh A, Naidu PS, Kulkarni SK.
    Eur J Pharmacol; 2003 Sep 12; 477(2):87-94. PubMed ID: 14519411
    [Abstract] [Full Text] [Related]

  • 17. Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol.
    Gao XM, Sakai K, Tamminga CA.
    Neuropsychopharmacology; 1998 Nov 12; 19(5):428-33. PubMed ID: 9778664
    [Abstract] [Full Text] [Related]

  • 18. Low doses of haloperidol interfere with rat tongue extensions during licking: a quantitative analysis.
    Fowler SC, Mortell C.
    Behav Neurosci; 1992 Apr 12; 106(2):386-95. PubMed ID: 1590957
    [Abstract] [Full Text] [Related]

  • 19. Similarities and differences between the subchronic and withdrawal effects of clozapine and olanzapine on forelimb force steadiness.
    Stanford JA, Fowler SC.
    Psychopharmacology (Berl); 1997 Aug 12; 132(4):408-14. PubMed ID: 9298520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.